|
DE3508258A1
(de)
*
|
1985-03-08 |
1986-09-18 |
Bayer Ag, 5090 Leverkusen |
Ss-lactamantibiotika, verfahren zur herstellung und ihre verwendung als und in arzneimitteln
|
|
FR2643903A1
(fr)
|
1989-03-03 |
1990-09-07 |
Union Pharma Scient Appl |
Nouveaux derives de benzimidazole, leurs procedes de preparation, intermediaires de synthese, compositions pharmaceutiques les contenant, utiles notamment pour le traitement des maladies cardiovasculaires, et des ulceres duodenaux
|
|
RU1836357C
(ru)
|
1990-07-23 |
1993-08-23 |
Др.Карл Томэ ГмбХ |
Производные бензимидазола, их изомеры, смеси изомеров, гидраты или их физиологически переносимые соли, обладающие антагонистическими в отношении ангиотензина свойствами
|
|
DE4023369A1
(de)
|
1990-07-23 |
1992-01-30 |
Thomae Gmbh Dr K |
Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
|
US5614519A
(en)
|
1991-02-06 |
1997-03-25 |
Karl Thomae Gmbh |
(1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists
|
|
DE4224752A1
(de)
|
1992-04-11 |
1994-02-03 |
Thomae Gmbh Dr K |
Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
DE4225756A1
(de)
|
1992-01-22 |
1994-03-10 |
Thomae Gmbh Dr K |
Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
SI9210098B
(sl)
|
1991-02-06 |
2000-06-30 |
Dr. Karl Thomae |
Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
|
|
US5125961A
(en)
|
1991-08-12 |
1992-06-30 |
Monsanto Company |
Substituted pyridine compounds
|
|
DE4219534A1
(de)
|
1992-02-19 |
1993-12-16 |
Thomae Gmbh Dr K |
Substituierte Biphenylylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
DE4408497A1
(de)
|
1994-03-14 |
1995-09-21 |
Thomae Gmbh Dr K |
Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
JPH10503768A
(ja)
|
1994-08-02 |
1998-04-07 |
メルク シヤープ エンド ドーム リミテツド |
アゼチジン、ピロリジンおよびピペリジン誘導体
|
|
RU2135493C1
(ru)
|
1995-04-21 |
1999-08-27 |
Нюросерч А/С |
Производное бензимидазола, фармацевтический состав и способ модуляции гамка-рецепторного комплекса
|
|
JP2000072675A
(ja)
|
1998-08-26 |
2000-03-07 |
Tanabe Seiyaku Co Ltd |
医薬組成物
|
|
EP1144387A1
(en)
|
1998-12-04 |
2001-10-17 |
Neurosearch A/S |
New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
|
|
US6380235B1
(en)
*
|
1999-05-04 |
2002-04-30 |
American Home Products Corporation |
Benzimidazolones and analogues
|
|
US6664252B2
(en)
|
1999-12-02 |
2003-12-16 |
Osi Pharmaceuticals, Inc. |
4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
|
|
GB0002100D0
(en)
|
2000-01-28 |
2000-03-22 |
Novartis Ag |
Organic compounds
|
|
US20020019395A1
(en)
|
2000-02-01 |
2002-02-14 |
Bing-Yan Zhu |
Indalone and benzimidazolone inhibitors of factor Xa
|
|
US20120028912A1
(en)
|
2000-02-22 |
2012-02-02 |
J.David Gladstone Institute |
Methods of modulating bromodomains
|
|
EP1337150A4
(en)
|
2000-10-27 |
2007-09-26 |
Dow Agrosciences Llc |
SUBSTITUTED 4,5-DIHYDRO-1,2,4-TRIAZIN-6-ONE, 1,2,4-TRIAZIN-6-ONE AND THEIR USE AS FUNGICIDES AND INSECTICIDES
|
|
AP1893A
(en)
*
|
2000-12-01 |
2008-09-23 |
Osi Pharm Inc |
Compounds specific to adenosine A1, A2A and A3 receptor and uses thereof
|
|
JP3616628B2
(ja)
|
2001-03-01 |
2005-02-02 |
塩野義製薬株式会社 |
Ｈｉｖインテグラーゼ阻害活性を有する含窒素芳香族複素環化合物
|
|
CA2440211A1
(en)
|
2001-03-09 |
2002-09-19 |
Pfizer Products Inc. |
Benzimidazole anti-inflammatory compounds
|
|
JP4251438B2
(ja)
|
2001-03-15 |
2009-04-08 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
Ｈｉｖ阻害性ピラジノン誘導体
|
|
US20030125344A1
(en)
*
|
2001-03-23 |
2003-07-03 |
Bayer Corporation |
Rho-kinase inhibitors
|
|
US7081454B2
(en)
|
2001-03-28 |
2006-07-25 |
Bristol-Myers Squibb Co. |
Tyrosine kinase inhibitors
|
|
CN1514833A
(zh)
|
2001-03-28 |
2004-07-21 |
����˹�ж�-����˹˹������˾ |
新型酪氨酸激酶抑制剂
|
|
US20050176858A1
(en)
|
2002-02-15 |
2005-08-11 |
Bridgestone Corporation |
Rubber composition and pneumatic tire made therefrom
|
|
TWI276631B
(en)
|
2002-09-12 |
2007-03-21 |
Avanir Pharmaceuticals |
Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
|
|
US20040166137A1
(en)
|
2002-11-08 |
2004-08-26 |
Lackey John William |
Hetero-substituted benzimidazole compounds and antiviral uses thereof
|
|
AR043063A1
(es)
*
|
2002-12-13 |
2005-07-13 |
Altana Pharma Ag |
Bencimidazoles 6-sustituidos y su uso como inhibidores de secreciones gastricas
|
|
AR042956A1
(es)
*
|
2003-01-31 |
2005-07-13 |
Vertex Pharma |
Inhibidores de girasa y usos de los mismos
|
|
CL2004000409A1
(es)
*
|
2003-03-03 |
2005-01-07 |
Vertex Pharma |
Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu
|
|
WO2004098494A2
(en)
|
2003-04-30 |
2004-11-18 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
|
AU2003902860A0
(en)
|
2003-06-06 |
2003-06-26 |
Daicel Chemical Industries, Ltd |
Benzimidazole compounds
|
|
EP1651198A2
(en)
|
2003-08-08 |
2006-05-03 |
Avanir Pharmaceuticals |
Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases
|
|
CL2004002050A1
(es)
|
2003-08-13 |
2005-06-03 |
Pharmacia Corp Sa Organizada B |
Compuestos derivados de piridinonas sustituidas; su uso en el tratamiento de afecciones causadas o exacerbadas por actividad p38 map kinasa y/o tnf no regulada, tales como inflamaciones, tumores, sida y otros.
|
|
WO2005080380A1
(en)
|
2004-02-03 |
2005-09-01 |
Eli Lilly And Company |
Kinase inhibitors
|
|
WO2005075432A1
(ja)
|
2004-02-06 |
2005-08-18 |
Chugai Seiyaku Kabushiki Kaisha |
１−（２ｈ）−イソキノロン誘導体およびその抗ガン剤としての使用
|
|
CN1285590C
(zh)
|
2004-02-23 |
2006-11-22 |
上海医药工业研究院 |
伊曲康唑盐酸盐口服固体组合物和制备方法
|
|
WO2005090317A1
(en)
|
2004-03-23 |
2005-09-29 |
F.Hoffmann-La Roche Ag |
Non-nucleoside reverse transcriptase inhibitors
|
|
EP1734820A4
(en)
|
2004-04-16 |
2008-01-23 |
Neurogen Corp |
Imidazopyrrazine, imidazopyridine, and imidazo-pyrimidine as CRF1 receptor ligands
|
|
NZ551775A
(en)
|
2004-06-01 |
2010-12-24 |
Univ Virginia |
Dual small molecule inhibitors of cancer and angiogenesis
|
|
WO2005121132A1
(ja)
|
2004-06-11 |
2005-12-22 |
Shionogi & Co., Ltd. |
抗ｈｃｖ作用を有する縮合ヘテロ環化合物
|
|
BRPI0514687A
(pt)
|
2004-08-26 |
2008-06-17 |
Pfizer |
compostos amino heteroarila como inibidores de proteìna tirosina cinase
|
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
WO2006038734A1
(en)
|
2004-10-08 |
2006-04-13 |
Astellas Pharma Inc. |
Pyridazinone derivatives cytokines inhibitors
|
|
WO2006045010A2
(en)
|
2004-10-20 |
2006-04-27 |
Resverlogix Corp. |
Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
|
|
RS52458B
(sr)
|
2005-02-04 |
2013-02-28 |
Millennium Pharmaceuticals Inc. |
Inhibitori e1 aktivirajućih enzima
|
|
ES2400287T3
(es)
|
2005-03-14 |
2013-04-08 |
High Point Pharmaceuticals, Llc |
Derivados de benzazol, composiciones y procedimientos de uso como inhibidores de beta-secretasa
|
|
CN101189214A
(zh)
|
2005-05-03 |
2008-05-28 |
美国陶氏益农公司 |
取代的4，5-二氢-1，2，4-三嗪-6-酮、1，2，4-三嗪-6-酮及其作为杀菌剂的用途
|
|
CA2617213C
(en)
|
2005-07-29 |
2014-01-28 |
Resverlogix Corp. |
Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
|
|
RU2008112691A
(ru)
|
2005-10-03 |
2009-10-10 |
Оно Фармасьютикал Ко., Лтд. (Jp) |
Азотсодержащее гетероциклическое соединение и его фармацевтическое применение
|
|
JP2009515997A
(ja)
|
2005-11-18 |
2009-04-16 |
タケダ サン ディエゴ インコーポレイテッド |
グルコキナーゼ活性剤
|
|
WO2007063012A1
(en)
*
|
2005-12-01 |
2007-06-07 |
F. Hoffmann-La Roche Ag |
Heteroaryl substituted piperidine derivatives as l-cpt1 inhibitors
|
|
WO2007093901A1
(en)
*
|
2006-02-17 |
2007-08-23 |
Pfizer Limited |
3 -deazapurine derivatives as tlr7 modulators
|
|
CN101384593A
(zh)
*
|
2006-02-17 |
2009-03-11 |
辉瑞有限公司 |
用作tlr7调节剂的3-脱氮嘌呤衍生物
|
|
JP5255559B2
(ja)
*
|
2006-03-31 |
2013-08-07 |
アボット・ラボラトリーズ |
インダゾール化合物
|
|
AR060237A1
(es)
|
2006-04-03 |
2008-06-04 |
Glaxo Group Ltd |
Compuesto de 3-azabiciclo[3.1.0]hexano como moduladores del receptor de dopamina d3, su uso para la preparacion de un medicamento para el tratamiento de afecciones psicoticas y composicion farmaceutica que lo comprende.
|
|
WO2008054599A2
(en)
|
2006-09-27 |
2008-05-08 |
Surface Logix, Inc. |
Rho kinase inhibitors
|
|
ES2383239T3
(es)
|
2006-12-14 |
2012-06-19 |
Astellas Pharma Inc. |
Compuestos de ácidos policíclicos útiles como antagonistas de CRTH2 y como agentes antialérgicos
|
|
SG144809A1
(en)
|
2007-01-11 |
2008-08-28 |
Millipore U K Ltd |
Benzimidazole compounds and their use as chromatographic ligands
|
|
WO2008092231A1
(en)
|
2007-02-01 |
2008-08-07 |
Resverlogix Corp. |
Compounds for the prevention and treatment of cardiovascular diseases
|
|
WO2008153701A1
(en)
|
2007-05-24 |
2008-12-18 |
Schering Corporation |
Compounds for inhibiting ksp kinesin activity
|
|
JP5451602B2
(ja)
*
|
2007-06-08 |
2014-03-26 |
アッヴィ・インコーポレイテッド |
キナーゼ阻害薬としての５−ヘテロアリール置換インダゾール類
|
|
WO2009000413A1
(en)
|
2007-06-26 |
2008-12-31 |
Sanofi-Aventis |
A regioselective copper catalyzed synthesis of benzimidazoles and azabenzimidazoles
|
|
DE102007032507A1
(de)
|
2007-07-12 |
2009-04-02 |
Merck Patent Gmbh |
Pyridazinonderivate
|
|
DE102007038957A1
(de)
|
2007-08-17 |
2009-02-19 |
Merck Patent Gmbh |
6-Thioxo-pyridazinderivate
|
|
GB0719235D0
(en)
|
2007-10-02 |
2007-11-14 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2009054790A1
(en)
|
2007-10-26 |
2009-04-30 |
Astrazeneca Ab |
Amide linked heteroaromatic derivatives as modulators of mglur5
|
|
JP2011506322A
(ja)
|
2007-12-07 |
2011-03-03 |
エラン ファーマシューティカルズ，インコーポレイテッド |
液性腫瘍を治療するための方法および組成物
|
|
WO2009079001A1
(en)
|
2007-12-18 |
2009-06-25 |
Janssen Pharmaceutica N.V. |
Bicyclic heteroaryl-substituted imidazoles as modulators of the histamine h4 receptor
|
|
WO2009084693A1
(ja)
|
2007-12-28 |
2009-07-09 |
Mitsubishi Tanabe Pharma Corporation |
抗癌剤
|
|
TW200942537A
(en)
*
|
2008-02-01 |
2009-10-16 |
Irm Llc |
Compounds and compositions as kinase inhibitors
|
|
WO2009158258A1
(en)
|
2008-06-25 |
2009-12-30 |
E. I. Du Pont De Nemours And Company |
Herbicidal dihydro oxo six-membered azinyl isoxazolines
|
|
PE20110368A1
(es)
*
|
2008-08-18 |
2011-06-13 |
Univ Yale |
Moduladores de mif
|
|
US9540322B2
(en)
*
|
2008-08-18 |
2017-01-10 |
Yale University |
MIF modulators
|
|
US9643922B2
(en)
|
2008-08-18 |
2017-05-09 |
Yale University |
MIF modulators
|
|
CA2744498C
(en)
|
2008-11-25 |
2017-10-24 |
University Of Rochester |
Mlk inhibitors and methods of use
|
|
PT2370413E
(pt)
|
2008-12-08 |
2015-10-23 |
Arena Pharm Inc |
Moduladores do recetor da prostaciclina (pgi2) úteis para o tratamento de distúrbios relacionados com o mesmo
|
|
EP2196465A1
(en)
|
2008-12-15 |
2010-06-16 |
Almirall, S.A. |
(3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
|
|
DE102008062826A1
(de)
|
2008-12-23 |
2010-07-01 |
Merck Patent Gmbh |
Pyridazinonderivate
|
|
US8389550B2
(en)
|
2009-02-25 |
2013-03-05 |
Hoffmann-La Roche Inc. |
Isoxazoles / O-pyridines with ethyl and ethenyl linker
|
|
US20120202793A1
(en)
|
2009-03-09 |
2012-08-09 |
Paul Sweetnam |
Rho kinase inhibitors
|
|
NZ755378A
(en)
|
2009-03-18 |
2022-07-29 |
Resverlogix Corp |
Novel quinazolinones and related compounds for use as anti-inflammatory agents
|
|
WO2010107739A2
(en)
|
2009-03-18 |
2010-09-23 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions of treating a flaviviridae family viral infection
|
|
KR20190091564A
(ko)
|
2009-04-22 |
2019-08-06 |
리스버로직스 코퍼레이션 |
신규한 소염제
|
|
KR101367012B1
(ko)
|
2009-05-05 |
2014-03-14 |
에프. 호프만-라 로슈 아게 |
이속사졸-피리딘 유도체
|
|
GB0919431D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
ES2563057T3
(es)
|
2009-11-05 |
2016-03-10 |
Glaxosmithkline Llc |
Inhibidor de bromodominio de benzodiazepina
|
|
GB0919434D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB0919423D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB0919432D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Use
|
|
RS54645B1
(sr)
|
2009-11-05 |
2016-08-31 |
Glaxosmithkline Llc |
Benzodiazepin kao inhibitor bromodomena
|
|
US9034850B2
(en)
|
2009-11-20 |
2015-05-19 |
Sk Chemicals Co., Ltd. |
Gonadotropin releasing hormone receptor antagonist, preparation method thereof and pharmaceutical composition comprising the same
|
|
EP2507231A1
(en)
*
|
2009-12-03 |
2012-10-10 |
Glaxo Group Limited |
Indazole derivatives as pi 3 - kinase inhibitors
|
|
WO2011097607A1
(en)
|
2010-02-08 |
2011-08-11 |
Southern Research Institute |
Anti-viral treatment and assay to screen for anti-viral agent
|
|
KR101165996B1
(ko)
|
2010-04-23 |
2012-07-18 |
주식회사 녹십자 |
프탈라지논 유도체, 이의 제조방법 및 이를 함유하는 약학적 조성물
|
|
PL2902030T3
(pl)
|
2010-05-14 |
2017-07-31 |
Dana-Farber Cancer Institute, Inc. |
Związki tienotriazolodiazepinowe do leczenia nowotworu
|
|
JP2011246389A
(ja)
*
|
2010-05-26 |
2011-12-08 |
Oncotherapy Science Ltd |
Ｔｔｋ阻害作用を有する縮環ピラゾール誘導体
|
|
US8933096B2
(en)
|
2010-06-09 |
2015-01-13 |
Rugers, The State University of New Jersey |
Antimicrobial agents
|
|
WO2011159926A1
(en)
|
2010-06-16 |
2011-12-22 |
Rutgers, The State University Of New Jersey |
Antimicrobial agents
|
|
CA2803448A1
(en)
|
2010-07-06 |
2012-01-12 |
Universite De Montreal |
Imidazopyridine, imidazopyrimidine and imidazopyrazine derivatives as melanocortin-4 receptor modulators
|
|
WO2012009258A2
(en)
|
2010-07-13 |
2012-01-19 |
Edward Roberts |
Peptidomimetic galanin receptor modulators
|
|
US8993779B2
(en)
|
2010-08-12 |
2015-03-31 |
Merck Sharp & Dohme Corp. |
Positive allosteric modulators of MGLUR2
|
|
WO2012040499A2
(en)
|
2010-09-22 |
2012-03-29 |
Surface Logix, Inc. |
Metabolic inhibitors
|
|
KR101242572B1
(ko)
|
2010-10-12 |
2013-03-19 |
한국화학연구원 |
5-환 헤테로 아릴로 치환된 프탈라지논 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 약학적 조성물
|
|
GB201018147D0
(en)
|
2010-10-27 |
2010-12-08 |
Glaxo Group Ltd |
Method of treatment
|
|
AR084070A1
(es)
|
2010-12-02 |
2013-04-17 |
Constellation Pharmaceuticals Inc |
Inhibidores del bromodominio y usos de los mismos
|
|
US9249161B2
(en)
|
2010-12-02 |
2016-02-02 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
CN102731409A
(zh)
|
2011-04-08 |
2012-10-17 |
中国科学院上海药物研究所 |
一类哒嗪酮类化合物，其药物组合物、制备方法及用途
|
|
GB201106743D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201106799D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201106750D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
|
GB201107325D0
(en)
|
2011-05-04 |
2011-06-15 |
Glaxosmithkline Llc |
Novel compounds
|
|
EP2721031B1
(en)
*
|
2011-06-17 |
2016-01-20 |
Constellation Pharmaceuticals, Inc. |
Bromodomain inhibitors and uses thereof
|
|
GB201114103D0
(en)
|
2011-08-17 |
2011-09-28 |
Glaxosmithkline Llc |
Novel compounds
|
|
WO2013027168A1
(en)
|
2011-08-22 |
2013-02-28 |
Pfizer Inc. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
WO2013047813A1
(ja)
*
|
2011-09-30 |
2013-04-04 |
大鵬薬品工業株式会社 |
１，２，４－トリアジン－６－カルボキサミド誘導体
|
|
RU2640115C2
(ru)
|
2011-11-01 |
2017-12-26 |
Ресверлоджикс Корп. |
Фармацевтические композиции замещенных хиназолинонов
|
|
DK2785710T3
(en)
|
2011-12-01 |
2017-12-04 |
Chemocentryx Inc |
SUBSTITUTED BENZIMIDAZOLES AND BENZOPYRAZOLES AS CCR (4) - ANTAGONISTS
|
|
WO2013097052A1
(en)
|
2011-12-30 |
2013-07-04 |
Abbott Laboratories |
Bromodomain inhibitors
|
|
US20130281396A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US20130281397A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US20130281398A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
US20130281399A1
(en)
|
2012-04-19 |
2013-10-24 |
Rvx Therapeutics Inc. |
Treatment of diseases by epigenetic regulation
|
|
EP2838881B1
(en)
|
2012-04-20 |
2018-08-08 |
AbbVie Inc. |
Isoindolone derivatives
|
|
EP2864336B1
(en)
|
2012-06-06 |
2016-11-23 |
Constellation Pharmaceuticals, Inc. |
Benzo[b]isoxazoloazepine bromodomain inhibitors and uses thereof
|
|
US9550737B2
(en)
|
2012-06-11 |
2017-01-24 |
Ucb Biopharma Sprl |
TNF -α modulating benzimidazoles
|
|
US20140073634A1
(en)
|
2012-08-24 |
2014-03-13 |
Institute For Applied Cancer Science/The University of Texas MD Anderson Cancer Center |
Heterocyclic modulators of hif activity for treatment of disease
|
|
EA201590482A1
(ru)
|
2012-09-05 |
2015-07-30 |
Байер Кропсайенс Аг |
Применение замещенных 2-амидобензимидазолов, 2-амидобензоксазолов и 2-амидобензотиазолов или их солей в качестве биологически активных веществ против абиотического стресса растений
|
|
WO2014043246A1
(en)
|
2012-09-11 |
2014-03-20 |
The Board Of Trustees Of The University Of Illinois |
Enoyl reductase inhibitors with antibacterial activity
|
|
EP2920183B1
(en)
|
2012-11-14 |
2017-03-08 |
Glaxosmithkline LLC |
Thieno[3,2-c]pyridin-4(5h)-ones as bet inhibitors
|
|
US9765039B2
(en)
|
2012-11-21 |
2017-09-19 |
Zenith Epigenetics Ltd. |
Biaryl derivatives as bromodomain inhibitors
|
|
US9073878B2
(en)
|
2012-11-21 |
2015-07-07 |
Zenith Epigenetics Corp. |
Cyclic amines as bromodomain inhibitors
|
|
HK1211033A1
(en)
|
2012-12-20 |
2016-05-13 |
Bayer Pharma Aktiengesellschaft |
Bet-protein-inhibiting dihydroquinoxalinones
|
|
AU2013365926B9
(en)
|
2012-12-21 |
2019-01-17 |
Zenith Epigenetics Ltd. |
Novel heterocyclic compounds as bromodomain inhibitors
|
|
EP2958923A1
(de)
|
2013-02-22 |
2015-12-30 |
Bayer Pharma Aktiengesellschaft |
4-substituierte pyrrolo- und pyrazolo-diazepine
|
|
US20160009725A1
(en)
|
2013-02-22 |
2016-01-14 |
Bayer Pharma Aktiengesellschaft |
Pyrrolo- and pyrazolo-triazolodiazepines as bet-protein inhibitors for treating hyperproliferative diseases
|
|
WO2014128655A1
(en)
|
2013-02-25 |
2014-08-28 |
Aurigene Discovery Technologies Limited |
Substituted imidazo[4,5-c]quinoline derivatives as bromodomain inhibitors
|
|
US9492460B2
(en)
|
2013-02-27 |
2016-11-15 |
Bristol-Myers Squibb Company |
Carbazole compounds useful as bromodomain inhibitors
|
|
CN105189488B
(zh)
|
2013-02-27 |
2018-07-24 |
百时美施贵宝公司 |
用作溴区结构域抑制剂的咔唑化合物
|
|
EP2970312B1
(en)
|
2013-03-11 |
2017-11-15 |
The Regents of The University of Michigan |
Bet bromodomain inhibitors and therapeutic methods using the same
|
|
CN105164127A
(zh)
|
2013-03-11 |
2015-12-16 |
艾伯维公司 |
溴结构域抑制剂
|
|
BR112015022674A2
(pt)
|
2013-03-11 |
2017-07-18 |
Abbvie Inc |
inibidores de bromodomínio
|
|
EP2970193B1
(en)
|
2013-03-12 |
2018-07-25 |
AbbVie Inc. |
Pyrrole amide inhibitors
|
|
US9321764B2
(en)
|
2013-03-12 |
2016-04-26 |
Abbvie Inc. |
Dihydro-pyrrolopyridinone inhibitors
|
|
JP6464139B2
(ja)
|
2013-03-14 |
2019-02-06 |
コンバージーン・リミテッド・ライアビリティ・カンパニーＣｏｎｖｅｒｇｅｎｅ Ｌｌｃ |
ブロモドメイン含有タンパク質の阻害のための方法および組成物
|
|
WO2014140077A1
(en)
|
2013-03-14 |
2014-09-18 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Furopyridines as bromodomain inhibitors
|
|
NZ710765A
(en)
|
2013-03-14 |
2020-05-29 |
Glaxosmithkline Ip No 2 Ltd |
2,3-disubstituted 1 -acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors
|
|
MX366703B
(es)
|
2013-03-15 |
2019-07-22 |
Incyte Holdings Corp |
Heterociclos tricíclicos como inhibidores de la proteína bet.
|
|
CA2904364A1
(en)
|
2013-03-15 |
2014-09-25 |
Epigenetix, Inc. |
Oxazolo[5,4-c]quinolin-2-one compounds as bromodomain inhibitors
|
|
US20140303121A1
(en)
|
2013-03-15 |
2014-10-09 |
Plexxikon Inc. |
Heterocyclic compounds and uses thereof
|
|
SG11201506687RA
(en)
|
2013-03-15 |
2015-09-29 |
Plexxikon Inc |
Heterocyclic compounds and uses thereof
|
|
JP6453845B2
(ja)
|
2013-03-27 |
2019-01-16 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｂｒｄ４阻害薬としてのジヒドロキナゾリノン類似体
|
|
US9102684B2
(en)
|
2013-03-27 |
2015-08-11 |
Boehringer Ingelheim International Gmbh |
Indolinone analogues
|
|
TWI530499B
(zh)
|
2013-03-28 |
2016-04-21 |
吉李德科學股份有限公司 |
作為溴結構域（ｂｒｏｍｏｄｏｍａｉｎ）抑制劑之苯並咪唑酮衍生物類
|
|
EP2996689A1
(en)
|
2013-04-17 |
2016-03-23 |
Albert-Ludwigs-Universität Freiburg |
Compounds for use as bromodomain inhibitors
|
|
EP2792355A1
(en)
|
2013-04-17 |
2014-10-22 |
Albert-Ludwigs-Universität Freiburg |
Compounds for use as bromodomain inhibitors
|
|
EA027139B1
(ru)
|
2013-04-26 |
2017-06-30 |
Бейджин, Лтд. |
Замещенные 5-(3,5-диметилизоксазол-4-ил)индолин-2-оны
|
|
TWI527811B
(zh)
|
2013-05-09 |
2016-04-01 |
吉李德科學股份有限公司 |
作爲溴結構域抑制劑的苯並咪唑衍生物
|
|
US8975417B2
(en)
|
2013-05-27 |
2015-03-10 |
Novartis Ag |
Pyrazolopyrrolidine derivatives and their use in the treatment of disease
|
|
MX2015016344A
(es)
|
2013-05-27 |
2016-03-01 |
Novartis Ag |
Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades.
|
|
WO2014202578A1
(de)
|
2013-06-17 |
2014-12-24 |
Bayer Pharma Aktiengesellschaft |
Substituierte phenyl-2,3-benzodiazepine
|
|
CA2915838C
(en)
|
2013-06-21 |
2023-04-18 |
Zenith Epigenetics Corp. |
Bicyclic bromodomain inhibitors
|
|
EP3010918B1
(en)
|
2013-06-21 |
2018-08-15 |
Zenith Epigenetics Ltd. |
Novel substituted bicyclic compounds as bromodomain inhibitors
|
|
AR096758A1
(es)
|
2013-06-28 |
2016-02-03 |
Abbvie Inc |
Inhibidores cristalinos de bromodominios
|
|
AR096837A1
(es)
|
2013-07-08 |
2016-02-03 |
Incyte Corp |
Heterociclos tricíclicos como inhibidores de proteínas bet
|
|
WO2015011084A1
(de)
|
2013-07-23 |
2015-01-29 |
Bayer Pharma Aktiengesellschaft |
Substituierte dihydropyrido[3,4-b]pyrazinone als duale inhibitoren von bet-proteinen und polo-like kinasen
|
|
AU2014292888B2
(en)
|
2013-07-25 |
2018-03-22 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of transcription factors and uses thereof
|
|
JP6542212B2
(ja)
|
2013-07-31 |
2019-07-10 |
ゼニス・エピジェネティクス・リミテッドＺｅｎｉｔｈ Ｅｐｉｇｅｎｅｔｉｃｓ Ｌｔｄ． |
ブロモドメイン阻害剤としての新規キナゾリノン
|
|
US20150051208A1
(en)
|
2013-08-14 |
2015-02-19 |
Boehringer Ingelheim International Gmbh |
Pyridinones
|
|
CN106029076B
(zh)
|
2013-11-18 |
2019-06-07 |
福马疗法公司 |
作为bet溴域抑制剂的苯并哌嗪组合物
|
|
JP6553632B2
(ja)
|
2013-11-18 |
2019-07-31 |
フォーマ セラピューティクス，インコーポレイテッド |
Ｂｅｔブロモドメイン阻害剤としてのテトラヒドロキノリン組成物
|
|
GB201321739D0
(en)
|
2013-12-09 |
2014-01-22 |
Ucb Pharma Sa |
Therapeutic agents
|
|
US9458156B2
(en)
|
2014-12-23 |
2016-10-04 |
Bristol-Myers Squibb Company |
Tricyclic compounds as anticancer agents
|
|
EP3227281A4
(en)
|
2014-12-01 |
2018-05-30 |
Zenith Epigenetics Ltd. |
Substituted pyridinones as bromodomain inhibitors
|
|
HK1246273B
(en)
|
2014-12-01 |
2019-12-06 |
恒翼生物医药(上海)股份有限公司 |
Substituted pyridines as bromodomain inhibitors
|
|
EP3230277B1
(en)
|
2014-12-11 |
2019-09-18 |
Zenith Epigenetics Ltd. |
Substituted heterocycles as bromodomain inhibitors
|
|
US20190055235A1
(en)
|
2014-12-17 |
2019-02-21 |
Zenith Epigenetics Ltd. |
Substituted bicyclic compounds as bromodomain inhibitors
|
|
HK1245247A1
(zh)
|
2014-12-17 |
2018-08-24 |
恒翼生物医药科技(上海)有限公司 |
溴结构域的抑制剂
|